Formulary Chapter 25: A2 - Borderline substances - Full Chapter
|
Chapter Links... |
Clinical Commissioning Policy 277: Oral nutritional supplements (adults) |
OCCG Guidelines: Infant Formula Guidelines |
OCCG Guidelines: Infant Formula Guidelines Summary |
OCCG Patient Leaflet: Food first |
OCCG Patient Leaflet: Food fortification |
OCCG Patient Leaflet: High energy drinks |
OCCG Patient Leaflet: High energy snacks |
Details... |
A2.03.01 |
Specialised formulas: Infant and child |
|
|
Alimentum® (Extensively hydrolysed formula)
|
First Choice
|
For the management of Cow's milk protein allergy in children, in line with:
Lactose free and suitable from birth.
Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net.
APCO September 2017.
|
|
Aptamil Pepti® 1 (Extensively hydrolysed formula)
|
First Choice
|
For the management of Cow's milk protein allergy in children, in line with:
Contains lactose and may be used if there is a palatability issue. Suitable from birth to 6 months of age. Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. APCO September 2017.
|
|
Aptamil Pepti® 2 (Extensively hydrolysed formula)
|
First Choice
|
For the management of Cow's milk protein allergy in children, in line with:
Contains lactose and may be used if there is a palatability issue. Suitable from 6 months of age. Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. APCO September 2017.
|
|
Nutramigen 1 with LGG® (Extensively hydrolysed formula)
|
First Choice
|
Previously known as Nutramigen Lipil 1. For the management of Cow's milk protein allergy in children, in line with:
Lactose free and contains a unique probiotic Lactobacillus rhamnosus GG. Suitable from birth to 6 months of age. Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. APCO September 2017.
|
|
Nutramigen 2 with LGG® (Extensively hydrolysed formula)
|
First Choice
|
Previously known as Nutramigen Lipil 2. For the management of Cow's milk protein allergy in children, in line with:
Lactose free and contains a unique probiotic Lactobacillus rhamnosus GG. Suitable from 6 months of age. Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. APCO September 2017.
|
|
SMA Althera Powder® (Extensively hydrolysed formula)
|
First Choice
|
For the management of Cow's milk protein allergy in children, in line with:
Contains lactose and may be used if there is a palatability issue. Suitable from birth.
Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net.
APCO September 2017.
|
|
Aptamil Pepti-Junior® (Extensively hydrolysed formula with MCT (medium chain triglycerides))
|
Formulary
|
Suitable when cow's milk protein allergy is also accompanied by malabsorption.
Suitable for continuation in primary care following initiation or recommendation from a specialist or dietitian only, in line with:
Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net.
APCO September 2017.
|
|
Pregestimil Lipil® (Extensively hydrolysed formula with MCT (medium chain triglycerides))
|
Formulary
|
Suitable when cow's milk protein allergy is also accompanied by malabsorption. Suitable for continuation in primary care following initiation or recommendation from a specialist or dietitian only, in line with:
Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. APCO September 2017.
|
|
EleCare (Amino acid formula)
|
Formulary
|
Suitable for continuation in primary care following initiation or recommendation from a specialist or dietitian only, for the management of Cow's milk protein allergy in children. Also suitable where a low osmolarity infant formula with MCT is appropriate. Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net.
See:
APCO July 2020.
|
|
Infatrini® Peptisorb (Extensively hydrolysed formula)
|
Formulary
|
High calorie EHF to optimise caloric intake in poor feeders with multiple food intolerances and malabsorption. Suitable for continuation in primary care following initiation or recommendation from a specialist or dietitian only. See:
Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. APCO September 2017.
|
|
Neocate® Junior (Amino acid formula)
|
Formulary
|
Neocate® Junior will replace Neocate® Active and Neocate® Advance over a period of 12 months, from April 2017 to April 2018. These are high calorie formulas and will not be required automatically by all infants over 1 year. Suitable for continuation in primary care following initiation or recommendation from a specialist or dietitian only. Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. See:
APCO September 2017.
|
|
Nutramigen® Puramino (Amino acid formula)
|
Formulary
|
Suitable for continuation in primary care following initiation or recommendation from a specialist or dietitian only, for the management of Cow's milk protein allergy in children. Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. See:
APCO September 2017.
|
|
Locasol®
|
Formulary
|
Low calcium formula for children with conditions of calcium intolerance requiring restriction of calcium and vitamin D intake. Suitable for continuation in primary care following initiation or recommendation from a specialist or dietitian only.
|
|
SMA Alfamino® (Amino acid formula)
|
Formulary
|
Suitable for continuation in primary care following initiation or recommendation from a specialist or dietitian only, for the management of Cow's milk protein allergy in children. Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net.
See:
APCO September 2017.
|
|
|
|
|
|
|
|
|
|
|
|
.... |
Non Formulary Items |
Enfamil® AR

|
Non Formulary
|
Not recommended for prescribing, in line with Clinical Commissioning Policy 250B. Available to purchase over the counter. APCO September 2017. |
|
Enfamil® O-Lac

|
Non Formulary
|
Available to purchase over the counter for secondary lactose intolerance, in line with:
Lactose free milks are not licensed for the treatment of colic. See patient information leaflet on temporary lactose intolerance.
APCO May 2007 and September 2017.
Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. |
|
Neocate Syneo®

|
Non Formulary
|
Not recommended for prescribing due to lack of evidence.
APCO January 2020. |
|
Nutramigen 3 with LGG®

|
Non Formulary
|
Not recommended for prescribing, in most cases children over 12 months of age should be weaned off at this point.
APCO January 2020. |
|
SMA ® Anti-reflux

|
Non Formulary
|
Not recommended for prescribing, in line with Clinical Commissioning Policy 250B.
Available to purchase over the counter.
APCO September 2017. |
|
SMA LF®

|
Non Formulary
|
Available to purchase over the counter for secondary lactose intolerance, in line with:
Lactose free milks are not licensed for the treatment of colic. See patient information leaflet on temporary lactose intolerance.
APCO May 2007 and September 2017.
Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net. |
|
Wysoy®

|
Non Formulary
|
Not recommended for prescribing. Available to purchase over the counter.
See:
Note: All allergy related queries from GPs can be sent to oxon.paedsallergyadvice@nhs.net.
APCO September 2017. |
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
Status |
Description |

|
Red: Medicines which should only be prescribed in secondary care by a specialist. |

|
Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred. |

|
Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO). |

|
Green: Medicines which are suitable for initiation and ongoing prescribing within primary care. |

|
Brown: Medicines which should only be prescribed in restricted circumstances. |

|
Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety. |

|
not used |
|
|
|